FDA Drug Application (083643) for CAPITAL AND CODEINE by CARNRICK

Back to FDA Applications sponsored by CARNRICK

Application Number083643
Product Number001
FormTABLET;ORAL
Dosage325MG;30MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCAPITAL AND CODEINE
Active IngredientACETAMINOPHEN; CODEINE PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient ACETAMINOPHEN107
List of drugs with Active Ingredient CODEINE PHOSPHATE51


Back to FDA Applications sponsored by CARNRICK